A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer (Q41867717)

13 October 2017

A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancer (English)

1 reference

13 October 2017

0 references

1 reference

2

Thomas L Chenevert

1 reference

13 October 2017

Kyle C Cuneo

1

1 reference

13 October 2017

Edgar Ben-Josef

3

1 reference

13 October 2017

Mary U Feng

4

1 reference

13 October 2017

Joel K Greenson

5

1 reference

13 October 2017

Hero K Hussain

6

1 reference

13 October 2017

Diane M Simeone

7

1 reference

13 October 2017

Matthew J Schipper

8

1 reference

13 October 2017

Michelle A Anderson

9

1 reference

13 October 2017

Mark M Zalupski

10

1 reference

13 October 2017

Mahmoud Al-Hawary

11

1 reference

13 October 2017

Craig J Galban

12

1 reference

13 October 2017

Alnawaz Rehemtulla

13

1 reference

13 October 2017

Felix Y Feng

14

1 reference

13 October 2017

Theodore S Lawrence

15

1 reference

13 October 2017

Brian D Ross

16

1 reference

13 October 2017

24 October 2014

1 reference

13 October 2017

Translational Oncology

1 reference

13 October 2017

7

1 reference

13 October 2017

5

1 reference

13 October 2017

644-649

1 reference

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Radiochemotherapy in the management of pancreatic cancer--part I: neoadjuvant treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Diffusion MR imaging: clinical applications

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Cancer. Breaching the cancer fortress

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Advanced pancreatic cancer: the use of the apparent diffusion coefficient to predict response to chemotherapy

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Apparent diffusion coefficient in pancreatic cancer: characterization and histopathological correlations.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4225651

Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer

2 December 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TRANON.2014.07.005

Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TRANON.2014.07.005

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FJ.TRANON.2014.07.005

Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25389460

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.TRANON.2014.07.005

1 reference

13 October 2017

1 reference

13 October 2017

1 reference